News from emd serono A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 23, 2018, 09:26 ET EMD Serono R&D Building Earns First WELL Gold Certification™ in U.S. for New & Existing Building Project

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that its R&D facility's Sagamore ...

Apr 13, 2018, 12:06 ET EMD Serono Highlights Commitment to Advance Multiple Sclerosis Treatment with Investigational Cladribine Tablets and Rebif® Data at AAN 2018

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced data for Cladribine Tablets, an...

Mar 06, 2018, 09:21 ET Wendy Sussman Joins EMD Serono as Vice President of U.S. Healthcare Government & Public Affairs

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that Wendy Sussman has joined...

Feb 01, 2018, 08:30 ET EMD Serono to Present Data Highlighting Investigational Cladribine Tablets at ACTRIMS 2018

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced that six posters evaluating...

Dec 07, 2017, 07:00 ET John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced the appointment of John Walsh, M.D....

Dec 05, 2017, 07:00 ET EMD Serono Announces FDA 510(k) Clearance of Partner Genea Biomedx's Fertility Benchtop Incubator Geri™

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the FDA 510(k) clearance of the ...

Dec 01, 2017, 07:00 ET EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced the appointment of Zhen Su, M.D.,...

Nov 13, 2017, 07:00 ET EMD Serono Receives FDA Approval for New GONAL-f® RFF Redi-ject® Pen

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, received approval for a redesigned version of...

Nov 06, 2017, 08:00 ET New Survey Reveals Physical, Mental and Financial Challenges Faced by Caregivers in the United States

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, announced the results of the Embracing Carers™...

Nov 01, 2017, 09:00 ET EMD Serono And Lupus Foundation Of America Launch Initiative To Improve Future Of Lupus Care

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and the Lupus Foundation of America (Foundation)...

Oct 23, 2017, 09:07 ET EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced the appointment of Robert...

Sep 05, 2017, 09:02 ET Investigational Cladribine Tablets Demonstrates Sustained Disease Control over 4 Years with Maximum of 20 Days Oral Treatment

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced the publication of the results of ...

May 31, 2017, 06:15 ET EMD Serono Honors World MS Day by Launching Care Partner Survey with IACO

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, honors World MS Day 2017 by announcing a...

May 25, 2017, 08:00 ET EMD Serono to Present Data Highlighting Investigational Cladribine Tablets at CMSC 2017

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced 14 presentations, including eight ...

May 01, 2017, 12:26 ET 13th Annual EMD Serono Specialty Digest™ Details Utilization and Clinical Management Trends

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the launch of the 13th edition...

Apr 28, 2017, 09:00 ET Investigational Cladribine Tablets Data Show Greater Treatment Effect in Relapsing MS Patients at a Higher Risk of Disease Progression

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, announced the presentation of new analyses of...

Apr 21, 2017, 09:00 ET EMD Serono and Merck KGaA, Darmstadt, Germany to Present Rebif® (interferon beta-1a) and Investigational Cladribine Tablets Data at AAN 2017

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, will present data at the American Academy of...

Mar 22, 2017, 09:19 ET EMD Serono to Present Real-World Data Analyses at the Annual Pacific Coast Reproductive Society Meeting

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced two new real-world data...

Jan 17, 2017, 08:00 ET Richard R. Smith Joins EMD Serono as Senior Vice President and Head of US Fertility and Endocrinology

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that Richard R. Smith has...

Jan 09, 2017, 08:00 ET EMD Serono and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration

EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, and The University of Texas MD Anderson Cancer Center...

Nov 29, 2016, 08:17 ET FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review

If approved by the FDA, avelumab, an investigational immunotherapy, could be the first treatment indicated for patients with metastatic Merkel cell...

Oct 17, 2016, 10:00 ET EMD Serono Announces Launch of New Fertility Technologies Division at ASRM Annual Meeting

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the creation of a dedicated...

Sep 16, 2016, 09:17 ET EMD Serono Appoints Craig Millian Senior Vice President, Neurology and Immunology

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced the appointment of Craig Millian...

Aug 18, 2016, 09:00 ET EMD Serono Receives CEO Cancer Gold Standard™ Re-Accreditation

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that it has earned CEO Cancer...

Jul 06, 2016, 11:00 ET EMD Serono Commits €1.5 million to the Grant for Fertility Innovation (GFI) for 2016/17

EMD Serono, the U.S. biopharmaceutical business of Merck KGaA, Darmstadt, Germany, today announced it would continue to support the advancement of...